Market Place
Sourcing Support
Mithra postpones its annual general meeting
28 May 2024 //
GLOBENEWSWIRE
Mithra In Exclusive Talks With Richter, Secures Funding
03 May 2024 //
GLOBENEWSWIRE
Mithra Updates on Monetization Offers, Annual Report 2023
29 Apr 2024 //
GLOBENEWSWIRE
Mithra secures court protection measures to advance monetization process
22 Apr 2024 //
GLOBENEWSWIRE
Mithra reports full year 2023 financial results
08 Mar 2024 //
GLOBENEWSWIRE
Mithra initiates monetization process, receives bridge loan from lenders
05 Mar 2024 //
GLOBENEWSWIRE
Mithra announces changes to its executive management
05 Mar 2024 //
GLOBENEWSWIRE
DONESTA® safety study for menopause completes treatment phase
29 Feb 2024 //
GLOBENEWSWIRE
Mithra sells shares in Mayne Pharma
15 Feb 2024 //
GLOBENEWSWIRE
Mithra updates on cash position
06 Feb 2024 //
GLOBENEWSWIRE
Mithra and Rafa sign binding Head of Terms to commercialize DONESTA® in Israel
21 Dec 2023 //
GLOBENEWSWIRE
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
20 Dec 2023 //
GLOBENEWSWIRE
Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
18 Dec 2023 //
GLOBENEWSWIRE
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE
04 Dec 2023 //
GLOBENEWSWIRE
Mithra receives guidance from FDA for DONESTA NDA marketing authorization
30 Nov 2023 //
GLOBENEWSWIRE
Mithra to hold five presentations on key role of estrogens in womens health
28 Nov 2023 //
GLOBENEWSWIRE
Mithra™s NEXTSTELLIS® granted additional patent in the United States
07 Nov 2023 //
GLOBENEWSWIRE
Mithra releases invitation to its extraordinary securities holders™ meeting
06 Nov 2023 //
GLOBENEWSWIRE
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
26 Oct 2023 //
GLOBENEWSWIRE
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma
23 Oct 2023 //
GLOBENEWSWIRE
Mithra™s Board of Directors to propose the removal of its request for change of the remuneration policy
17 Oct 2023 //
GLOBENEWSWIRE
Shareholder Letter
11 Oct 2023 //
GLOBENEWSWIRE
Mithra to Hold Presentations on Key Role of Estrogens in Women™s Health
10 Oct 2023 //
GLOBENEWSWIRE
Mithra announces update to the agenda of special general shareholders™ meeting
10 Oct 2023 //
GLOBENEWSWIRE
Mithra Provides an Update in the Context of Recent Market Developments
05 Oct 2023 //
GLOBENEWSWIRE
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen
27 Sep 2023 //
GLOBENEWSWIRE
Mithra Financial Results for First-Half 2023
26 Sep 2023 //
GLOBENEWSWIRE
Information on the total number of voting rights (denominator)
21 Sep 2023 //
GLOBENEWSWIRE
Mithra to Hold Investor Call on H1 2023 Financial Results
21 Sep 2023 //
GLOBENEWSWIRE
Notice of Adjustment of the Conversion Price of Mithra`s EUR 125,000,000 Bonds
13 Sep 2023 //
GLOBENEWSWIRE
Publication of a Transparency Notification Received from Armistice Capital, LLC
13 Sep 2023 //
GLOBENEWSWIRE
Notice of Adjustment of the Conversion Price of Mithra`s EUR 125,000,000 Bonds
12 Sep 2023 //
GLOBENEWSWIRE
Publication of a Transparency Notification Received from Armistice Capital, LLC
12 Sep 2023 //
GLOBENEWSWIRE
Letter to Shareholders and Corporate Update
11 Sep 2023 //
GLOBENEWSWIRE
Mithra completes EUR 20 million private placement in equity denominator
28 Aug 2023 //
GLOBENEWSWIRE
Mithra prices private placement to raise EUR 20 million in equity
24 Aug 2023 //
GLOBENEWSWIRE
Mithra and Gedeon Sign Agreement for Production of API for Estelle and Donesta
08 Aug 2023 //
GLOBENEWSWIRE
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma
03 Aug 2023 //
GLOBENEWSWIRE
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
31 Jul 2023 //
BUSINESSWIRE
Notice of Adjustment of the Conversion Price of Mithra`s EUR 125,000,000 Bonds
17 Jul 2023 //
GLOBENEWSWIRE
Notice of Adjustment of the Conversion Price of Mithra`s EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
04 Jul 2023 //
GLOBENEWSWIRE
Mithra Announces Information on the Total Number of Voting Rights (Denominator)
26 Jun 2023 //
GLOBENEWSWIRE
Mithra has access to the new EUR 12.5 million tranche of the Highbridge
21 Jun 2023 //
GLOBENEWSWIRE
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program
15 Jun 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Scorpiaux BV
06 Jun 2023 //
PRESS RELEASE
Mithra - Publication of a transparency notification received from Scorpiaux BV
05 Jun 2023 //
GLOBENEWSWIRE
Mithra Appoints Executive Christian Homsy as Chairman
29 May 2023 //
PRESS RELEASE
Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman
29 May 2023 //
GLOBENEWSWIRE
Mithra’s Meeting Approves the Renewal of its Board of Directors
25 May 2023 //
PRESS RELEASE
Mithra - Letter to Shareholders and Corporate Update
25 May 2023 //
GLOBENEWSWIRE
Mithra General Meeting Of Shareholders Approves Renewal of Board of Directors
25 May 2023 //
GLOBENEWSWIRE
Payment of the interests of the Highbridge/Whitebox loans
12 May 2023 //
PRESS RELEASE
Mithra- Payment of the interests of the Highbridge/Whitebox loans Information
12 May 2023 //
GLOBENEWSWIRE
Mithra announces completion of recruitment in study of Estelle in patients
11 May 2023 //
PRESS RELEASE
Mithra Announces Completion of Recruitment in Pediatric Study of Estelle
10 May 2023 //
GLOBENEWSWIRE
Mithra and the University of Liège Secure Proof-of-Concept for E4
04 May 2023 //
PRESS RELEASE
Mithra & the of Liège Secure Proof-of-Concept for Novel MFG of Estetrol
04 May 2023 //
GLOBENEWSWIRE
Publication of a transparency notification received from Alychlo NV
28 Apr 2023 //
PRESS RELEASE
Mithra Releases Invitation to its General Shareholders’ Meeting
25 Apr 2023 //
PRESS RELEASE
Mithra Releases Invitation to its General Shareholdersâ Meeting
25 Apr 2023 //
GLOBENEWSWIRE
